PGAM1P13

Across TCGA pan-cancer cohorts, PGAM1P13 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated PGAM1P13 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher PGAM1P13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PGAM1P13 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KICH, COAD, and LGG are the cancer types where PGAM1P13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.025	0.900	<.001	99	view →
COAD	OS	Tertile	All	0.448	0.873	.003	27	view →
LGG	DFS	Tertile	All	0.234	0.745	<.001	27	view →
THYM	OS	Tertile	All	0.352	0.884	.014	18	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
GBM	OS	Tertile	All	0.212	0.421	.033	18	view →
HNSC	DFS	Tertile	IV	0.050	0.570	<.001	18	view →
THCA	DFS	Tertile	III,IV	0.145	0.825	<.001	18	view →
PRAD	OS	Tertile	All	0.869	0.990	<.001	12	view →
SKCM	DFS	Tertile	All	1.000	0.620	.026	9	view →
BRCA	OS	Tertile	III,IV	0.159	0.547	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

PGAM1P13–KICH (DFS)

Open the KICH breakdown →